Cellev8 Nutrition, Inc. CELV
Set alert
0.12 USD +0.01 +12.15%
At close · Oct 30
0.12 Day range 0.12
0.03 52-week range 0.35
- YTD
- -4.76%
- 1 year
- -25.00%
- Open
- 0.12
- Prev close
- 0.107
- Mkt cap
- 15.72M
- Vol
- 5.00K
- Avg vol
- 18.05K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.12
- High
- 0.12
3M chart
Signals (27)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| RSI: Overbought | Sep 30, 2026 | 1 month ago |
| RSI: Overbought | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
Financial health
Altman Z-Score
-337.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -8.5×
FY 2016 5y median -8.5× FY 2025
P/S 47.2×
FY 2016 5y median 482× FY 2025
P/B -10.4×
FY 2016 5y median -5.1× FY 2025
P/FCF -7.4×
FY 2016 5y median -21.1× FY 2025
EV/EBITDA -9.7×
FY 2016 5y median -11.1× FY 2025
EV/Sales 51.1×
FY 2016 5y median 521× FY 2025
FCF Yield -13.5%
FY 2016 5y median -4.7% FY 2025
Profitability
Gross Margin -63.1%
FY 2016 5y median 35.7% FY 2025
Operating Margin -526.8%
FY 2016 5y median -613.1% FY 2025
Net Margin -559.1%
FY 2016 5y median -559.1% FY 2025
ROE 123.0%
FY 2016 5y median 16.5% FY 2025
ROIC -621.4%
FY 2016 5y median 21.6% FY 2025
ROA -353.1%
FY 2016 5y median -243.7% FY 2025
Growth (YoY)
Revenue 42.8%
FY 2016 FY 2025
Operating Income -22.7%
FY 2016 FY 2025
EPS (diluted) -636.4%
FY 2016 FY 2025
Free Cash Flow -32.4%
FY 2016 FY 2025
Financial Health
Current Ratio 0.3×
FY 2016 5y median 0.1× FY 2025
Quick Ratio 0.2×
FY 2016 5y median 0.0× FY 2025
Debt / Equity -1.2×
FY 2016 5y median -0.8× FY 2025
Net Debt / EBITDA -0.7×
FY 2016 5y median -2.0× FY 2025
Interest Coverage -16.3×
FY 2016 5y median -6.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-11-30